Tetik Fatih, Korkut Arzu Yasemin, Kaya Kerem Sami, Ucak Irmak, Celebi Irfan, Coskun Berna Uslu
Department of Otorhinolaryngology Head and Neck Surgery, Gaziosmanpasa Taksim Training and Research Hospital, Istanbul, Turkey.
Department of Otorhinolaryngology Head and Neck Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Sisli Etfal Hastan Tip Bul. 2020 Jun 12;54(2):211-217. doi: 10.14744/SEMB.2018.40316. eCollection 2020.
In this study, our aim was to compare oral steroid therapy with macrolide therapy and with oral steroid + macrolide (combine) therapy in patients with nasal polyposis (NP).
All patients were treated with nasal steroid therapy for eight weeks and divided randomly into three groups as follows: Oral steroid group, oral macrolide group and combine group. All patients underwent endoscopic staging, radiological grading, odour testing and completed the sino-nasal outcome test-22 (SNOT-22) questionnaire before and after treatment.
Significant improvement was observed in all parameters after treatment in all three groups. All parameters were significantly better in the combined group than in the macrolide group. Comparison of the oral steroid group and macrolide group revealed significantly better radiological grading and odour test changes for the oral steroid group, but no statistically significant differences existed according to endoscopic staging and SNOT-22. The post-treatment SNOT-22 score was significantly better in the combined group than in the steroid group. A comparison of the combined and steroid groups showed better results for the combined group for all parameters, but the differences were not significant.
All treatment protocols were effective and the successful use of macrolide indicates its potential as an alternative in patients with contraindications to oral steroid treatment. The combined treatment may demonstrate significantly better results than steroid treatment alone if larger studies with more patients are performed.
在本研究中,我们的目的是比较口服类固醇疗法与大环内酯疗法以及口服类固醇+大环内酯(联合)疗法对鼻息肉(NP)患者的疗效。
所有患者均接受鼻用类固醇治疗8周,并随机分为三组:口服类固醇组、口服大环内酯组和联合组。所有患者在治疗前后均接受内镜分期、影像学分级、嗅觉测试,并完成鼻窦结局测试-22(SNOT-22)问卷。
三组患者治疗后所有参数均有显著改善。联合组的所有参数均显著优于大环内酯组。口服类固醇组和大环内酯组的比较显示,口服类固醇组的影像学分级和嗅觉测试变化显著更好,但在内镜分期和SNOT-22方面无统计学显著差异。联合组治疗后的SNOT-22评分显著优于类固醇组。联合组和类固醇组的比较显示,联合组在所有参数上的结果更好,但差异不显著。
所有治疗方案均有效,大环内酯的成功使用表明其在口服类固醇治疗禁忌患者中作为替代药物的潜力。如果进行更多患者的更大规模研究,联合治疗可能比单独使用类固醇治疗显示出显著更好的效果。